Adiponectin, which is reduced in obese people, is an adipokine that in the context of RA plays an inflammatory role correlating with disease activity in lean RA patients (25) and can potentiate joint damage (26). This evidence concerns the gene ADIPOQ and rheumatoid arthritis.